S. 3076: Nitazene Control Act
This bill, known as the Nitazene Control Act, aims to make significant changes to how certain synthetic opioids, specifically a class called nitazenes, are classified under U.S. law. Here’s a breakdown of the key components of the bill:
Purpose of the Bill
The primary goal of the Nitazene Control Act is to permanently classify nitazenes and similar substances as Schedule I controlled substances. This classification is important because it restricts the manufacturing, distribution, and possession of these drugs due to their high potential for abuse and lack of accepted medical use.
Findings
The bill includes several findings that provide the rationale for this action:
- Potency: Nitazenes are synthetic opioids that are significantly potent, with some even more powerful than fentanyl.
- Current Scheduling: The Drug Enforcement Administration (DEA) has already temporarily classified multiple nitazenes under Schedule I due to their danger.
- Public Health Concern: These substances have been appearing on the illicit drug market and are linked to overdoses and fatalities in the U.S.
- Proactive Measures: A permanent class-wide scheduling is necessary to effectively manage and control these substances, prevent the emergence of new analogs, and protect public health.
Changes to the Controlled Substances Act
The bill amends Section 202(c) of the Controlled Substances Act in the following ways:
1. Schedule I Classification
- The categorization of nitazenes, including any compounds associated with them, will be permanently added to Schedule I.
- This classification includes various specific derivatives and structural modifications of nitazenes that retain similar opioid receptor activity.
2. Removal of Temporary Status
All substances that were temporarily scheduled under the Controlled Substances Act will be permanently classified as Schedule I from the date when this act is enacted.
3. Research Limitations
The bill clarifies that new research involving these substances cannot be started without proper registration and adherence to the scheduling requirements set forth in the Act.
Overall Impact
The intent behind the Nitazene Control Act is to tighten regulations around nitazenes to prevent abuse and overdose cases associated with these potent synthetic opioids.
Relevant Companies
- None found
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
7 bill sponsors
Actions
2 actions
| Date | Action |
|---|---|
| Oct. 30, 2025 | Introduced in Senate |
| Oct. 30, 2025 | Read twice and referred to the Committee on the Judiciary. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.